While gene therapy is not yet widely available for inherited retinal disorsers (IRDs), researchers are making exciting discoveries, and the future looks more promising than ever before. In this issue of eye Insights, we provide a look into current offerings in gene therapy, and a glimpse into the exciting prospects brought forth by clinical trials being led by our own researchers at Mass Eye and Ear.
Inside
- IRDs and genetic testing
- Current gene therapies for IRDs
- Access to clinical trials
- Treatment and outcomes
Editor-in-Chief: Joan W. Miller, MD
Managing Editor: Matthew F. Gardiner, MD
Clinical Advisory Group: Deeba Husain, MD; Alice Lorch, MD, MPH; Ankoor Shah, MD, PhD
Publications Manager: Jessica O’Donnell
Graphic Design: Stone Studio Design
Contributor: Rachel M. Huckfeldt, MD, PhD
See also:
eye Insights